Additional file 1: of An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Bouton, Tara C
Phillips, Patrick PJ
Mitnick, Carole D
Peloquin, Charles A
Eisenach, Kathleen
Patientia, Ramonde F
Lecca, Leonid
Gotuzzo, Eduardo
Gandhi, Neel R
Butler, Donna
Diacon, Andreas H
Martel, Bruno
Santillan, Juan
Hunt, Kathleen Robergeau
Vargas, Dante
von Groote-Bidlingmaier, Florian
Seas, Carlos
Dianis, Nancy
Moreno-Martinez, Antonio
Horsburgh, C Robert

December 2017

BackgroundCurrent guidelines for treatment of multidrug-resistant tuberculosis (MDR-TB) are largely ...

Additional file 1: of Optimizing treatment protocols for spinal manipulative therapy: study protocol for a randomized trial

Julie Fritz (3585554)
Jason Sharpe (5338289)
Elizabeth Lane (5338286)
Doug Santillo (5338283)
Tom Greene (71869)
Gregory Kawchuk (5338280)

June 2018

2017 CONSORT checklist of information to include when reporting a randomized trial assessing nonphar...

Additional file 1: of Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial

Wei Wu (27708)
Heran Deng (580128)
Nanyan Rao (4535698)
Na You (4535695)
Yaping Yang (292220)
Minghui Cao (456943)
Jieqiong Liu (410671)

October 2017

SPIRIT Checklist. Checklist of the Standard Protocol Items: Recommendations for Interventional Trial...

Additional file 2: of An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Tara Bouton (4615357)
Patrick Phillips (1420741)
Carole Mitnick (4615363)
Charles Peloquin (594742)
Kathleen Eisenach (225003)
Ramonde Patientia (4615372)
Leonid Lecca (460651)
Eduardo Gotuzzo (20728)
Neel Gandhi (139419)
Donna Butler (4615345)
Andreas Diacon (3547031)
Bruno Martel (4615366)
Juan Santillan (4615354)
Kathleen Hunt (283294)
Dante Vargas (4615360)
Florian von Groote-Bidlingmaier (4615369)
Carlos Seas (308510)
Nancy Dianis (4615351)
Antonio Moreno-Martinez (4615348)
C. Horsburgh (4355272)

November 2017

OPTI-Q Study protocol version 1.6. This document provides the full protocol for the OPTI-Q Study as ...

Additional file 1: of Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)

James Seddon (2315008)
Anthony Garcia-Prats (6109229)
Susan Purchase (6109232)
Muhammad Osman (3515063)
Anne-Marie Demers (5123492)
Graeme Hoddinott (5123501)
Angela Crook (363156)
Ellen Owen-Powell (5123516)
Margaret Thomason (352864)
Anna Turkova (3480173)
Diana Gibb (324183)
Lee Fairlie (355761)
Neil Martinson (519159)
H. Schaaf (6109235)
Anneke Hesseling (402660)

December 2018

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

Myungsun Lee (384428)
Jeongha Mok (6238151)
Deog Kim (3531182)
Tae Shim (3504656)
Won-Jung Koh (139466)
Doosoo Jeon (4667782)
Taehoon Lee (423510)
Seung Lee (2985342)
Ju Kim (3501365)
Jae Park (3409286)
Ji Lee (273783)
Song Kim (3503126)
Jae Lee (2975361)
Kyung-Wook Jo (3863419)
Byung Jhun (6238154)
Young Kang (3572156)
Joong Ahn (3578549)
Chang-Ki Kim (6238157)
Soyoun Shin (6238160)
Taeksun Song (3447422)
Sung Shin (3401819)
Young Kim (4006)
Heejung Ahn (3745085)
Seokyung Hahn (611193)
Ho Won (6238163)
Ji Jang (3580541)
Sang Cho (6238166)
Jae-Joon Yim (139591)

January 2019

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patientsâ treatment adherence via electronic monitors and an app versus usual care in Tibet

Xiaolin Wei (287892)
Joseph Hicks (3553418)
Pande Pasang (6708692)
Zhitong Zhang (733339)
Victoria Haldane (4264357)
Xiaoqiu Liu (331744)
Tingting Yin (396811)
Lixia Wang (331745)
Dachun Shi (6708710)
Shiliang Ge (6708713)
John Walley (287897)
Ross Upshur (27475)
Jun Hu (5721)

May 2019

Standard Protocol items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist: recommen...

Additional file 1: of Is treatment outcome improved if patients match themselves to treatment options? Study protocol for a randomized controlled trial

Morten Hell (5072600)
William Miller (11991)
Bent Nielsen (1752817)
Anette Nielsen (5072603)

April 2018

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: a study protocol for a randomized controlled trial

Maguy El Hajj (6187868)
Ahmed Awaisu (5121473)
Nadir Kheir (47876)
Mohamad Mohamed (6187871)
Rula Haddad (6187874)
Rana Saleh (6187877)
Noora Alhamad (6187880)
Ahmad Almulla (6187883)
Ziyad Mahfoud (15883)

January 2019

Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist: recommen...

Additional file 1: of Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial

Patrick Nachipo (5681849)
David Hermann (731794)
Gerald Quinnan (5681852)
Melita Gordon (780111)
Wesley Van Voorhis (5681855)
Pui-Ying Iroh Tam (2578201)

August 2018

Standard protocol items: recommendation for interventional trials (Spirit) checklist. (DOC 190 kb

Additional file 1: of Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

Matthew Cheng (5314931)
Alexander Lawandi (5314943)
Guillaume Butler-Laporte (5314937)
Katryn Paquette (5314934)
Todd Lee (5314940)

May 2018

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Bouton, Tara C.
Phillips, Patrick P. J.
Mitnick, Carole D.
Peloquin, Charles A.
Eisenach, Kathleen
Patientia, Ramonde F.
Lecca, Leonid
Gotuzzo, Eduardo
Gandhi, Neel R.
Butler, Donna
Diacon, Andreas H.
Martel, Bruno
Santillan, Juan
Hunt, Kathleen Robergeau
Vargas, Dante
von Groote-Bidlingmaier, Florian
Seas, Carlos
Dianis, Nancy
Moreno-Martinez, Antonio
Horsburgh, C. Robert

January 2018

Background: Current guidelines for treatment of multidrug-resistant tuberculosis (MDR-TB) are largel...

Additional file 1: of Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-Î˛1b (MIRACLE trial): study protocol for a randomized controlled trial

Yaseen Arabi (652)
Adel Alothman (4808952)
Hanan Balkhy (3484613)
Abdulaziz Al-Dawood (4055134)
Sameera AlJohani (3632836)
Shmeylan Al Harbi (4808982)
Suleiman Kojan (4808991)
Majed Al Jeraisy (3548315)
Ahmad Deeb (478308)
Abdullah Assiri (4808976)
Fahad Al-Hameed (3484622)
Asim AlSaedi (4808973)
Yasser Mandourah (3492734)
Ghaleb Almekhlafi (3492740)
Nisreen Sherbeeni (4808949)
Fatehi Elzein (4808964)
Javed Memon (4808958)
Yusri Taha (4808961)
Abdullah Almotairi (4808985)
Khalid Maghrabi (4808979)
Ismael Qushmaq (62096)
Ali Al Bshabshe (4808970)
Ayman Kharaba (4808967)
Sarah Shalhoub (4808988)
Jesna Jose (4808955)
Robert Fowler (662365)
Frederick Hayden (273333)
Mohamed Hussein (4786770)

January 2018

SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of A targeted interprofessional educational intervention to address therapeutic adherence of venous leg ulcer persons (TIEIVLU): study protocol for a randomized controlled trial

Sebastian Probst (6649076)
Lara Allet (3216585)
Jocelyne Depeyre (6649079)
Sophie Colin (6649082)
Monika Buehrer Skinner (6649085)

April 2019

Standard protocol items: recommendation for interventional trials (SPIRIT) 2013 checklist: recommend...

Additional file 1: of A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial

Philip Schouten (3481448)
Gwen Dackus (3481442)
Serena Marchetti (3481445)
Harm van Tinteren (3481451)
Gabe Sonke (3481454)
Jan Schellens (62188)
Sabine Linn (832377)

June 2016

Revival study SPIRIT checklist. Description of the trial protocol with the SPIRIT checklist. (DOC 12...

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Bouton, Tara C
Phillips, Patrick PJ
Mitnick, Carole D
Peloquin, Charles A
Eisenach, Kathleen
Patientia, Ramonde F
Lecca, Leonid
Gotuzzo, Eduardo
Gandhi, Neel R
Butler, Donna
Diacon, Andreas H
Martel, Bruno
Santillan, Juan
Hunt, Kathleen Robergeau
Vargas, Dante
von Groote-Bidlingmaier, Florian
Seas, Carlos
Dianis, Nancy
Moreno-Martinez, Antonio
Horsburgh, C Robert

December 2017

BackgroundCurrent guidelines for treatment of multidrug-resistant tuberculosis (MDR-TB) are largely ...

Additional file 1: of Optimizing treatment protocols for spinal manipulative therapy: study protocol for a randomized trial

Julie Fritz (3585554)
Jason Sharpe (5338289)
Elizabeth Lane (5338286)
Doug Santillo (5338283)
Tom Greene (71869)
Gregory Kawchuk (5338280)

June 2018

2017 CONSORT checklist of information to include when reporting a randomized trial assessing nonphar...

Additional file 1: of Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial

Wei Wu (27708)
Heran Deng (580128)
Nanyan Rao (4535698)
Na You (4535695)
Yaping Yang (292220)
Minghui Cao (456943)
Jieqiong Liu (410671)

October 2017

SPIRIT Checklist. Checklist of the Standard Protocol Items: Recommendations for Interventional Trial...

Additional file 2: of An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Tara Bouton (4615357)
Patrick Phillips (1420741)
Carole Mitnick (4615363)
Charles Peloquin (594742)
Kathleen Eisenach (225003)
Ramonde Patientia (4615372)
Leonid Lecca (460651)
Eduardo Gotuzzo (20728)
Neel Gandhi (139419)
Donna Butler (4615345)
Andreas Diacon (3547031)
Bruno Martel (4615366)
Juan Santillan (4615354)
Kathleen Hunt (283294)
Dante Vargas (4615360)
Florian von Groote-Bidlingmaier (4615369)
Carlos Seas (308510)
Nancy Dianis (4615351)
Antonio Moreno-Martinez (4615348)
C. Horsburgh (4355272)

November 2017

OPTI-Q Study protocol version 1.6. This document provides the full protocol for the OPTI-Q Study as ...

Additional file 1: of Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)

James Seddon (2315008)
Anthony Garcia-Prats (6109229)
Susan Purchase (6109232)
Muhammad Osman (3515063)
Anne-Marie Demers (5123492)
Graeme Hoddinott (5123501)
Angela Crook (363156)
Ellen Owen-Powell (5123516)
Margaret Thomason (352864)
Anna Turkova (3480173)
Diana Gibb (324183)
Lee Fairlie (355761)
Neil Martinson (519159)
H. Schaaf (6109235)
Anneke Hesseling (402660)

December 2018

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial

Myungsun Lee (384428)
Jeongha Mok (6238151)
Deog Kim (3531182)
Tae Shim (3504656)
Won-Jung Koh (139466)
Doosoo Jeon (4667782)
Taehoon Lee (423510)
Seung Lee (2985342)
Ju Kim (3501365)
Jae Park (3409286)
Ji Lee (273783)
Song Kim (3503126)
Jae Lee (2975361)
Kyung-Wook Jo (3863419)
Byung Jhun (6238154)
Young Kang (3572156)
Joong Ahn (3578549)
Chang-Ki Kim (6238157)
Soyoun Shin (6238160)
Taeksun Song (3447422)
Sung Shin (3401819)
Young Kim (4006)
Heejung Ahn (3745085)
Seokyung Hahn (611193)
Ho Won (6238163)
Ji Jang (3580541)
Sang Cho (6238166)
Jae-Joon Yim (139591)

January 2019

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patientsâ treatment adherence via electronic monitors and an app versus usual care in Tibet

Xiaolin Wei (287892)
Joseph Hicks (3553418)
Pande Pasang (6708692)
Zhitong Zhang (733339)
Victoria Haldane (4264357)
Xiaoqiu Liu (331744)
Tingting Yin (396811)
Lixia Wang (331745)
Dachun Shi (6708710)
Shiliang Ge (6708713)
John Walley (287897)
Ross Upshur (27475)
Jun Hu (5721)

May 2019

Standard Protocol items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist: recommen...

Additional file 1: of Is treatment outcome improved if patients match themselves to treatment options? Study protocol for a randomized controlled trial

Morten Hell (5072600)
William Miller (11991)
Bent Nielsen (1752817)
Anette Nielsen (5072603)

April 2018

SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of Evaluation of an intensive education program on the treatment of tobacco-use disorder for pharmacists: a study protocol for a randomized controlled trial

Maguy El Hajj (6187868)
Ahmed Awaisu (5121473)
Nadir Kheir (47876)
Mohamad Mohamed (6187871)
Rula Haddad (6187874)
Rana Saleh (6187877)
Noora Alhamad (6187880)
Ahmad Almulla (6187883)
Ziyad Mahfoud (15883)

January 2019

Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Checklist: recommen...

Additional file 1: of Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial

Patrick Nachipo (5681849)
David Hermann (731794)
Gerald Quinnan (5681852)
Melita Gordon (780111)
Wesley Van Voorhis (5681855)
Pui-Ying Iroh Tam (2578201)

August 2018

Standard protocol items: recommendation for interventional trials (Spirit) checklist. (DOC 190 kb

Additional file 1: of Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

Matthew Cheng (5314931)
Alexander Lawandi (5314943)
Guillaume Butler-Laporte (5314937)
Katryn Paquette (5314934)
Todd Lee (5314940)

May 2018

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Bouton, Tara C.
Phillips, Patrick P. J.
Mitnick, Carole D.
Peloquin, Charles A.
Eisenach, Kathleen
Patientia, Ramonde F.
Lecca, Leonid
Gotuzzo, Eduardo
Gandhi, Neel R.
Butler, Donna
Diacon, Andreas H.
Martel, Bruno
Santillan, Juan
Hunt, Kathleen Robergeau
Vargas, Dante
von Groote-Bidlingmaier, Florian
Seas, Carlos
Dianis, Nancy
Moreno-Martinez, Antonio
Horsburgh, C. Robert

January 2018

Background: Current guidelines for treatment of multidrug-resistant tuberculosis (MDR-TB) are largel...

Additional file 1: of Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-Î˛1b (MIRACLE trial): study protocol for a randomized controlled trial

Yaseen Arabi (652)
Adel Alothman (4808952)
Hanan Balkhy (3484613)
Abdulaziz Al-Dawood (4055134)
Sameera AlJohani (3632836)
Shmeylan Al Harbi (4808982)
Suleiman Kojan (4808991)
Majed Al Jeraisy (3548315)
Ahmad Deeb (478308)
Abdullah Assiri (4808976)
Fahad Al-Hameed (3484622)
Asim AlSaedi (4808973)
Yasser Mandourah (3492734)
Ghaleb Almekhlafi (3492740)
Nisreen Sherbeeni (4808949)
Fatehi Elzein (4808964)
Javed Memon (4808958)
Yusri Taha (4808961)
Abdullah Almotairi (4808985)
Khalid Maghrabi (4808979)
Ismael Qushmaq (62096)
Ali Al Bshabshe (4808970)
Ayman Kharaba (4808967)
Sarah Shalhoub (4808988)
Jesna Jose (4808955)
Robert Fowler (662365)
Frederick Hayden (273333)
Mohamed Hussein (4786770)

January 2018

SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documen...

Additional file 1: of A targeted interprofessional educational intervention to address therapeutic adherence of venous leg ulcer persons (TIEIVLU): study protocol for a randomized controlled trial

Sebastian Probst (6649076)
Lara Allet (3216585)
Jocelyne Depeyre (6649079)
Sophie Colin (6649082)
Monika Buehrer Skinner (6649085)

April 2019

Standard protocol items: recommendation for interventional trials (SPIRIT) 2013 checklist: recommend...

Additional file 1: of A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial

Philip Schouten (3481448)
Gwen Dackus (3481442)
Serena Marchetti (3481445)
Harm van Tinteren (3481451)
Gabe Sonke (3481454)
Jan Schellens (62188)
Sabine Linn (832377)

June 2016

Revival study SPIRIT checklist. Description of the trial protocol with the SPIRIT checklist. (DOC 12...

An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Bouton, Tara C
Phillips, Patrick PJ
Mitnick, Carole D
Peloquin, Charles A
Eisenach, Kathleen
Patientia, Ramonde F
Lecca, Leonid
Gotuzzo, Eduardo
Gandhi, Neel R
Butler, Donna
Diacon, Andreas H
Martel, Bruno
Santillan, Juan
Hunt, Kathleen Robergeau
Vargas, Dante
von Groote-Bidlingmaier, Florian
Seas, Carlos
Dianis, Nancy
Moreno-Martinez, Antonio
Horsburgh, C Robert

December 2017

BackgroundCurrent guidelines for treatment of multidrug-resistant tuberculosis (MDR-TB) are largely ...

Additional file 1: of Optimizing treatment protocols for spinal manipulative therapy: study protocol for a randomized trial

Julie Fritz (3585554)
Jason Sharpe (5338289)
Elizabeth Lane (5338286)
Doug Santillo (5338283)
Tom Greene (71869)
Gregory Kawchuk (5338280)

June 2018

2017 CONSORT checklist of information to include when reporting a randomized trial assessing nonphar...

Additional file 1: of Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial

Wei Wu (27708)
Heran Deng (580128)
Nanyan Rao (4535698)
Na You (4535695)
Yaping Yang (292220)
Minghui Cao (456943)
Jieqiong Liu (410671)

October 2017

SPIRIT Checklist. Checklist of the Standard Protocol Items: Recommendations for Interventional Trial...

Additional file 1: of An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Abstract

Extracted data

Additional file 1: of An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial

Abstract

Extracted data

Related items

Related items